<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <billNumber>892</billNumber>
    <createDate>2017-04-08T00:41:49Z</createDate>
    <updateDate>2020-12-05T11:28:33Z</updateDate>
    <originChamber>Senate</originChamber>
    <billType>S</billType>
    <introducedDate>2017-04-07</introducedDate>
    <congress>115</congress>
    <recordedVotes />
    <committees>
      <billCommittees>
        <item>
          <systemCode>ssju00</systemCode>
          <name>Judiciary Committee</name>
          <chamber>Senate</chamber>
          <type>Standing</type>
          <subcommittees />
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-04-07T14:30:03Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <committeeReports />
    <relatedBills>
      <item>
        <latestTitle>Opioid Abuse Deterrence, Research, and Recovery Act of 2017</latestTitle>
        <congress>115</congress>
        <number>4482</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2018-01-09</actionDate>
          <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <latestTitle>Opioid Addiction Prevention Act of 2017</latestTitle>
        <congress>115</congress>
        <number>4408</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2017-12-13</actionDate>
          <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <latestTitle>Opioid Addiction Prevention Act of 2017</latestTitle>
        <congress>115</congress>
        <number>3964</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2017-10-16</actionDate>
          <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2017-04-07</actionDate>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on the Judiciary.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2017-04-07</actionDate>
        <links />
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <actionTypeCounts>
        <referredToCommittee>1</referredToCommittee>
        <introducedInSenate>1</introducedInSenate>
      </actionTypeCounts>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
    </actions>
    <sponsors>
      <item>
        <bioguideId>G000555</bioguideId>
        <fullName>Sen. Gillibrand, Kirsten E. [D-NY]</fullName>
        <firstName>Kirsten</firstName>
        <middleName>E.</middleName>
        <lastName>Gillibrand</lastName>
        <party>D</party>
        <state>NY</state>
        <identifiers>
          <lisID>1866</lisID>
          <bioguideId>G000555</bioguideId>
          <gpoId>8336</gpoId>
        </identifiers>
        <byRequestType />
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>M000303</bioguideId>
        <fullName>Sen. McCain, John [R-AZ]</fullName>
        <firstName>JOHN</firstName>
        <middleName>SIDNEY</middleName>
        <lastName>MCCAIN</lastName>
        <party>R</party>
        <state>AZ</state>
        <identifiers>
          <lisID>754</lisID>
          <bioguideId>M000303</bioguideId>
          <gpoId>8253</gpoId>
        </identifiers>
        <sponsorshipDate>2017-04-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>M001183</bioguideId>
        <fullName>Sen. Manchin, Joe, III [D-WV]</fullName>
        <firstName>Joe</firstName>
        <middleName />
        <lastName>Manchin</lastName>
        <party>D</party>
        <state>WV</state>
        <identifiers>
          <lisID>1983</lisID>
          <bioguideId>M001183</bioguideId>
          <gpoId>8256</gpoId>
        </identifiers>
        <sponsorshipDate>2018-01-18</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
    </cosponsors>
    <cboCostEstimates />
    <laws />
    <notes />
    <policyArea>
      <name>Crime and Law Enforcement</name>
    </policyArea>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Drug, alcohol, tobacco use</name>
          </item>
          <item>
            <name>Health personnel</name>
          </item>
          <item>
            <name>Licensing and registrations</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Crime and Law Enforcement</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2017-04-07</actionDate>
          <actionDesc>Introduced in Senate</actionDesc>
          <lastSummaryUpdateDate>2018-02-13T14:48:56Z</lastSummaryUpdateDate>
          <text><![CDATA[<p><b>Opioid Addiction Prevention Act of 2017</b></p> <p>This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to limit an opioid prescription for the initial treatment of acute pain to the lesser of a seven-day supply (no refill) or an opioid prescription limit established under state law.</p> <p>An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit. </p>]]></text>
          <updateDate>2017-04-07T04:00:00Z</updateDate>
          <name>Introduced in Senate</name>
        </item>
      </billSummaries>
    </summaries>
    <title>Opioid Addiction Prevention Act of 2017</title>
    <titles>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <parentTitleType />
        <title>Opioid Addiction Prevention Act of 2017</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <title>A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
        <title>Opioid Addiction Prevention Act of 2017</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Display Title</titleType>
        <parentTitleType />
        <title>Opioid Addiction Prevention Act of 2017</title>
        <chamberCode />
        <chamberName />
      </item>
    </titles>
    <amendments />
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2017-04-07T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115s892is/xml/BILLS-115s892is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2017-04-07</actionDate>
      <text>Read twice and referred to the Committee on the Judiciary.</text>
      <links />
    </latestAction>
    <calendarNumbers />
    <version>1.0.0</version>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

